PTP 546 Module 6 Cardiovascular Pharmacology: Part II Jayne Hansche Lobert, MS, RN, ACNS-BC, NP 1Lobert.

Slides:



Advertisements
Similar presentations
Chapter 19 Hematologic Products.
Advertisements

CLIs OMS I Fall 2013 Block 2. MOSBY’S Cholesterol (166 – 170) Normal Findings: Adult:
Agents Used in the Treatment of Hyperlipidemia
Drugs for Coagulation Disorders
Drugs for Coagulation Disorders Andrew N. Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University October 8, 2008
Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Blood.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
Medications that impact bleeding By Nino Lalaiants Inesa Legrian NYCCT 2012.
Vascular Pharmacology
Treating Stroke With Drug Therapies Michael Faithe, Pharm.D., BCPS Neurosciences Clinical Pharmacy Specialist University of Colorado Hospital.
Drugs and Dyslipidemias (statins and other lipid and atherosclerosis-modifying drugs) October 18, 2006 Frank F. Vincenzi.
Anticoagulation in the Acute Care Population Aimee Ring PT, DPT, GCS.
Principles of anticoagulant tratment
Antiplatelet Drugs (Anti-thrombotics)
Hemostasis and Blood Coagulation
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Coagulation Modifier Drugs.
ANTICOAGULANT BY :DR ISRAA OMAR.
ANTILIPEMICS LILLEY, READING & WORKBOOK: CHAP 28 Cardiovascular System.
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
WARFARIN AN OVERVIEW.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
ANTICOAGULANT, THROMBOLYTICS & ANTIPLATELET DRUGS.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 29 Antilipemic Drugs.
The Antihyperlipidemic Medications l Classifications of Lipoproteins – Chylomicrons l Formed in the mucosal cells of the gut l Protein coated dietary lipids.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.
Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.
Hperlipidemia:- Treatment and Management Presented by:- Dr. Tewari.
Antihyperlipidemia.
Anticoagulants 1. Parenteral Anticoagulants e.g. heparin
Drugs for Coagulation disorders. There are a number of different categories of drugs which modify the coagulation process: I. Anticoagulants II. Antiplatelet.
To Clot Or Not To Clot… Emergency Care for Coagulation Disorders/Conditions Rebecca Goldsmith Pediatric Thrombosis/Hemophilia Nurse McMaster Children’s.
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 27 Coagulation Modifier Drugs.
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
Anticoagulations and Coagulants
Drugs Used to Treat Thromboembolic Disorders Chapter 27 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Fibrinolytics, anticoagulants and antiplatelets
Antiplatelet drugs Dr.V.V.Gouripur. Antiplatelet drug An antiplatelet drug is a member of a class of drugs that decreases platelet aggregation and inhibits.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Antilipemic Drugs.
Agents Affecting Blood Clotting
Dr. Laila M. Matalqah Ph.D. Pharmacology
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.
Anticoagulants, Antiplatelets, and Thrombolytics
Anticoagulants Course: Pharmacology I Course Code: PHR 213 Course Instructor: Sabiha Chowdhury Lecturer Department of Pharmacy BRAC University.
Anticoagulant Therapy
50 Drugs that Help Normalize Cholesterol & Triglyceride Levels
Drugs Used in Coagulation Disorders
Pharmacotherapy Preview Program (P3) Antiplatelet Agents Anticoagulants Thrombolytics Lipid Lowering Medications Brandon Dyson, PharmD, BCPS.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs.
Chapter 23 Thrombo-Embolic diseases
23 Anticoagulants.
Blood/Blood Formation
Anticoagulants, Antiplatelets, and Thrombolytics
Drugs for Lipid Disorders
Management of ST-Elevation Myocardial Infarction
Anticoagulants in the Treatment of Venous Thromboembolism
The normal haemostasis process involves three stages: 1
Coagulation Modifier Drugs
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
Cardiovascular System
Antilipemic Agents Lilley Pharmacology Text: Chapter 27
Chapter 17 Hematologic Products
23 Anticoagulants.
Anticoagulants.
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Presentation transcript:

PTP 546 Module 6 Cardiovascular Pharmacology: Part II Jayne Hansche Lobert, MS, RN, ACNS-BC, NP 1Lobert

Cardiovascular Pharmacology Drugs used to treat excessive clot formation – Anticoagulants (only stop you for making new clots, they do NOT break down clots) Heparin Low Molecular Weight Heparin (Lovenox) Warfarin (Coumadin) – Antithrombotics Aspirin Clopidogrel (Plavix) – Thrombolytics Streptokinase (Streptase) 2Lobert

Cardiovascular Pharmacology Anticoagulant – Ex: Heparin (special spot, niche for action) – Action: potentiates antithrombin  renders clotting factors inactive; inhibits synthesis and function of clotting factors – Therapeutic Effect: prevents clot formation; prevents extension of existing venous thromboembolism (VTE prophylaxsis) – Side Effects: Bleeding (gums, bruises, urine, stool, internal bleeding) ; thrombocytopenia (platelet reduction in blood, so huge potential to bleed); HIT  increased thrombosis (opposite effect, freak thing) – Note: requires extensive monitoring of labs (PTT) For PT it may mean limiting exercise: look at PPT and platelet count. 3Lobert

Cardiovascular Pharmacology Anticoagulant – Ex: Low Molecular Weight Heparin Enoxaprin (Lovenox-done in home setting, super expensive so need insurance); Dalteparin (Fragmin) – Action: Inhibits synthesis of clotting factors – Therapeutic Effect: prevention of clot formation and prevention of extension of an existing venous thromboembolism – Side Effect: Bleeding- – Requires less monitoring 4Lobert

Cardiovascular Pharmacology Anticoagulant – Ex: Fondaparinux (Arixtra) – Action: inhibits clotting factor Xa  prevention of clot formation – Therapeutic Effect: prevention of venous (VTE) thromboembolism for patients at risk ex: post op orthopedic surgery; immobile – Side Effects: Bleeding 5Lobert

Cardiovascular Pharmacology Anticoagulant – Ex: Warfarin (Coumadin)-super common/easy – Action: inhibits vitamin K  decreases synthesis of clotting factors II, VII, IX, X Leafy greens could not be processed so increased rate of clotting. – Therapeutic Effect: long term prevention of blood clots in persons with valve replacements, atrial fibrillation, DVT history – Side Effects: bleeding Pts. are commonly admitted to the hospital for Coumadin toxicity – Note: requires long term lab analysis of PT/INR Pro-time/International normalized ratio (want INR to be 2-3 seconds, lower if A-Fib) Lobert6

Cardiovascular Pharmacology Antithrombotic Drugs – Ex: Aspirin – Action: suppress of proaggregation substances  inhibition of platelet aggregation – Therapeutic Effect: prevention of myocardial infarction, prevention of cerebral ischemia/stroke – Side Effects: gi upset, gi bleeding; tinnitus at high doses Baby aspirin: 81mg – Monitor Hgb: normal (12 females,14-16 males), 7Lobert

Cardiovascular Pharmacology Antithrombic Drugs: ADP Receptor Inhibitors – Ex: Clopidogrel (Plavix), used to prevention of MI when have a high risk – Action: inhibits ADP (a compound that increases platelet activity) – Therapeutic Effect: prevention of myocardial infarction; ischemic stroke and peripheral vascular diseases – Side Effects: Bleeding 8Lobert

Cardiovascular Pharmacology Thombolytics “take away a clot” – Ex: Streptokinase (Streptase);t-PA (alteplase) – Action: converts plasminogen to plasmin the enzyme which breaks down clots – Therapeutic Effect: treatment of ischemic strokes, myocardial infarctions; treatment of peripheral arterial occlusions; treatment of occluded venous access devices Have a therapeutic window, when given 1hr inside window then reduce death rate by 50%. – Side Effects: intracerebral hemorrhage; bleeding 9Lobert

Cardiovascular Pharmacology Agents used to treat hyperlipidemia – HMG-CoA Reductase Inhibitors (Statins) Simvastatin (Zocor) Lovastatin (Mevacor) – Fibric Acid Agents Gemfibrozil (Lopid) Fenofibrate (Tricor) – Cholesterol Absorption Inhibitor Ezetimbe (Zetia) 10Lobert

Cardiovascular Pharmacology Statins – Ex: Lovastatin (Mevacor); Simvastatin (Zocor) – Action: inhibits critical enzyme for cholesterol production  decrease cholesterol production – Therapeutic Effect: decrease levels of LDL and triglycerides with moderate increase in HDL  (HDL can also be increased with exercise) – Side Effects: nausea, cramping, myopathies-muscle pain, rhabdomyolysis-kidney faliure, liver dysfunction – Labs 6 to 12 months to check liver enzymes 11Lobert

Cardiovascular Pharmacology Fibric Acid Agents – Ex: Gemfibrozil (Lopid); Fenofibrate (Tricor) – Action: mechanism is unknown – Therapeutic Effects: decreases triglyceride levels, increased HDL – Side Effects: abdominal pain, fatigue, nausea and vomiting, liver dysfunction 12Lobert

Cardiovascular Pharmacology Cholesterol Absorption Inhibitors – Ex: Ezetimibe (Zetia) – Action: inhibits cholesterol absorption production in the GI tract – Therapeutic Effect: reduces LDL & triglycerides; increased HDL – Side Effects: gi distress, abdominal pain 13Lobert